127 related articles for article (PubMed ID: 11728978)
1. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
Hovind P; Tarnow L; Rossing P; Teerlink T; Stehouwer CD; Emeis JJ; Parving HH
Am J Kidney Dis; 2001 Dec; 38(6):1376-80. PubMed ID: 11728978
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
4. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
[TBL] [Abstract][Full Text] [Related]
6. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
Murussi M; Gross JL; Silveiro SP
J Diabetes Complications; 2006; 20(4):210-5. PubMed ID: 16798471
[TBL] [Abstract][Full Text] [Related]
7. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for progression of renal disease in patient with diabetic nephropathy.
Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
[TBL] [Abstract][Full Text] [Related]
9. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
Rossing P; Rossing K; Gaede P; Pedersen O; Parving HH
Diabetes Care; 2006 May; 29(5):1024-30. PubMed ID: 16644632
[TBL] [Abstract][Full Text] [Related]
10. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
[TBL] [Abstract][Full Text] [Related]
11. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
Björck S; Blohmé G; Sylvén C; Mulec H
Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
[TBL] [Abstract][Full Text] [Related]
12. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
Andrésdóttir G; Bakker SJ; Hansen HP; Parving HH; Rossing P
Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103
[TBL] [Abstract][Full Text] [Related]
13. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Rossing P; Hommel E; Smidt UM; Parving HH
Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
[TBL] [Abstract][Full Text] [Related]
14. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
[TBL] [Abstract][Full Text] [Related]
15. Risks for glomerular filtration rate decline in association with progression of albuminuria in type 2 diabetes.
Yokoyama H; Kanno S; Takahashi S; Yamada D; Honjo J; Saito K; Sone H; Haneda M
Nephrol Dial Transplant; 2011 Sep; 26(9):2924-30. PubMed ID: 21303964
[TBL] [Abstract][Full Text] [Related]
16. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T
Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747
[TBL] [Abstract][Full Text] [Related]
17. New and old markers of progression of diabetic nephropathy.
Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
[TBL] [Abstract][Full Text] [Related]
18. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes.
Morita M; Uchigata Y; Hanai K; Ogawa Y; Iwamoto Y
Am J Kidney Dis; 2011 Dec; 58(6):915-20. PubMed ID: 21763044
[TBL] [Abstract][Full Text] [Related]
19. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
[TBL] [Abstract][Full Text] [Related]
20. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance.
Veldman BA; Vervoort G; Blom H; Smits P
Diabet Med; 2005 Mar; 22(3):301-5. PubMed ID: 15717878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
